Recipharm Reduces Risk and Improves Compliance with Infor

United States – July 08, 2015, 09:00 AM

Recipharm today announces that it has deployed Infor M3 from Infor, the industry cloud company. Infor Enterprise Resource Planning (ERP) application will help reduce risk by enabling standard processes across all Recipharm manufacturing facilities in Sweden. Infor M3 will also help Recipharm continue to improve compliance with the European Union's GMP (EU-GMP) code of practice.

Following a period of organic and acquisitive growth, Recipharm sought to streamline its ERP system as part of a strategy to reduce the risks presented by a fragmented suite of legacy applications. Following a lengthy selection process, Infor M3 was chosen as it needed fewer customizations, was quicker to implement and offered a lower total cost of ownership.

The application was implemented by Infor partner Merit Globe. The project included integration with third party systems as well as a migration from IBM AS/400 to Microsoft SQL.

"Infor M3 is inherently less complex than comparable systems, and we were impressed by Infor's substantial investment in the application," said Mikael Porat, director of supply chain, Recipharm. "We can see that new features are being developed and industry-specific functionality added, removing the need for customization. This is critical for us as we instigate business process improvement projects."

"Success in the pharmaceutical industry depends on managing two contrasting factors, continual product innovation and complete compliance with regulations," said Mike Edgett, industry and solution strategy director, process manufacturing, Infor. "From an operational perspective this means an agile ERP and standardized processes are critical. Customizations must be kept to a minimum and integration must be lightweight and flexible to support growth. Through implementing Infor M3 throughout its operations, Recipharm can have confidence that both of these driving forces are being supported.

For more information, please visit: www.recipharm.com or contact:
Mikael Porat, Director of supply chain, mikael.porat@recipharm.com, + 46 8 602 52 10
Kjell Johansson, EVP COO Recipharm, kjell.johansson@recipharm.com, + 46 739 622 620

For media enquiries, please contact: Tristan Jervis or Alex Heeley at De Facto Communications on: E-mail: t.jervis@defacto.com or a.heeley@defacto.com, Tel: +44 (0) 207 861 3019/304

Filed Under
  • Press Releases
Industry
  • Other
Product
  • Other
Region
  • North America
Let’s Connect

We'll be in touch.